White label – Pompe disease - ClinicalTrials.eu

Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

Recruiting

3 1 1
Investigated Diseases:
- Polymyalgia rheumatica
Investigated Drugs:
- Sarilumab
- Prednisone
+3
Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Recruiting

3 1 1
Investigated Drugs:
- Durvalumab
- Mk-1084
+1
Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Recruiting

4 1 1 1
Investigated Drugs:
- Blinatumomab
- Tocilizumab
+1
Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

Recruiting

3 1 1 1
Investigated Diseases:
- Pneumonia bacterial
Investigated Drugs:
Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

Recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
+8
Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

Recruiting

3 1 1 1
Investigated Drugs:
Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

Recruiting

3 1 1 1
Investigated Drugs:
Semaglutide for weight management in adults with obesity and binge‑eating: a study to identify who benefits

Recruiting

3 1 1 1
Investigated Diseases:
- Obesity
Investigated Drugs:
- Semaglutide
Long‑term immunity after a 6‑month‑old MMR vaccine (live attenuated) in infants: follow‑up of antibody levels 1‑3 years after routine vaccination

Recruiting

3 1 1 1
Investigated Diseases:
- Measles
- Mumps
- Rubella
Investigated Drugs:
- RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

Recruiting

4 1 1 1
Investigated Diseases:
- Follicular lymphoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies